These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36480378)

  • 1. A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease.
    Curiel Cid RE; Matias-Guiu JA; Loewenstein DA
    Neuropsychology; 2023 Sep; 37(6):661-672. PubMed ID: 36480378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease.
    Cid REC; Loewenstein DA
    Neurotherapeutics; 2022 Jan; 19(1):89-98. PubMed ID: 35246818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    Loewenstein DA; Curiel Cid RE; Kitaigorodsky M; Ortega A; Hincapie D; Zheng DD; Amaya A; Gallardo L; Manso L; Sosa J; Crocco EA
    J Alzheimers Dis; 2022; 90(1):313-322. PubMed ID: 36155503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.
    Crocco EA; Loewenstein DA; Curiel RE; Alperin N; Czaja SJ; Harvey PD; Sun X; Lenchus J; Raffo A; Peñate A; Melo J; Sang L; Valdivia R; Cardenas K
    J Psychiatr Res; 2018 Jan; 96():33-38. PubMed ID: 28957712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Cognitive Paradigms for the Detection of Memory Impairment in Preclinical Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Duara R; Buschke H
    Assessment; 2018 Apr; 25(3):348-359. PubMed ID: 29214859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.
    Loewenstein DA; Curiel RE; DeKosky S; Rosselli M; Bauer R; Grieg-Custo M; Penate A; Li C; Lizagarra G; Golde T; Adjouadi M; Duara R
    J Alzheimers Dis; 2017; 59(1):131-139. PubMed ID: 28598850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to Recover from Proactive Semantic Interference and Abnormal Limbic Connectivity in Asymptomatic, Middle-Aged Offspring of Patients with Late-Onset Alzheimer's Disease.
    Sánchez SM; Abulafia C; Duarte-Abritta B; de Guevara MSL; Castro MN; Drucaroff L; Sevlever G; Nemeroff CB; Vigo DE; Loewenstein DA; Villarreal MF; Guinjoan SM
    J Alzheimers Dis; 2017; 60(3):1183-1193. PubMed ID: 28984601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method of evaluating semantic intrusion errors to distinguish between amyloid positive and negative groups on the Alzheimer's disease continuum.
    Curiel Cid RE; Crocco EA; Duara R; Garcia JM; Rosselli M; DeKosky ST; Smith G; Bauer R; Chirinos CL; Adjouadi M; Barker W; Loewenstein DA
    J Psychiatr Res; 2020 May; 124():131-136. PubMed ID: 32146222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semantic intrusion errors as a function of age, amyloid, and volumetric loss: a confirmatory path analysis.
    Zheng DD; Curiel Cid RE; Duara R; Kitaigorodsky M; Crocco E; Loewenstein DA
    Int Psychogeriatr; 2022 Nov; 34(11):991-1001. PubMed ID: 33455613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.
    Valles-Salgado M; Cabrera-Martín MN; Curiel-Cid RE; Delgado-Álvarez A; Delgado-Alonso C; Gil-Moreno MJ; Matías-Guiu J; Loewenstein DA; Matias-Guiu JA
    J Alzheimers Dis; 2022; 90(2):823-840. PubMed ID: 36189601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
    Loewenstein DA; Curiel RE; DeKosky S; Bauer RM; Rosselli M; Guinjoan SM; Adjouadi M; Peñate A; Barker WW; Goenaga S; Golde T; Greig-Custo MT; Hanson KS; Li C; Lizarraga G; Marsiske M; Duara R
    Neurology; 2018 Sep; 91(10):e976-e984. PubMed ID: 30076274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.
    Loewenstein DA; Curiel RE; Wright C; Sun X; Alperin N; Crocco E; Czaja SJ; Raffo A; Penate A; Melo J; Capp K; Gamez M; Duara R
    J Alzheimers Dis; 2017; 56(3):1119-1126. PubMed ID: 28106554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of deficits in semantic cueing and proactive and retroactive interference as early features of Alzheimer's disease.
    Crocco E; Curiel RE; Acevedo A; Czaja SJ; Loewenstein DA
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):889-97. PubMed ID: 23768680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia.
    Eliassen IV; Fladby T; Kirsebom BE; Waterloo K; Eckerström M; Wallin A; Bråthen G; Aarsland D; Hessen E
    Neuropsychology; 2020 Nov; 34(8):851-861. PubMed ID: 33197198
    [No Abstract]   [Full Text] [Related]  

  • 16. Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials.
    Loewenstein DA; Curiel Cid RE; Kitaigorodsky M; Crocco EA; Zheng DD; Gorman KL
    J Prev Alzheimers Dis; 2021; 8(2):181-187. PubMed ID: 33569565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel measures for Alzheimer's disease prevention trials (NoMAD).
    Bell SA; Cohen HR; Lee S; Kim H; Ciarleglio A; Andrews H; Rivera AM; Igwe K; Brickman AM; Devanand DP; Harvey PD; Schneider LS; Goldberg TE
    Contemp Clin Trials; 2021 Jul; 106():106425. PubMed ID: 33933666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
    BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer's Disease.
    Hudd F; Shiel A; Harris M; Bowdler P; McCann B; Tsivos D; Wearn A; Knight M; Kauppinen R; Coulthard E; White P; Conway ME
    J Alzheimers Dis; 2019; 67(3):931-947. PubMed ID: 30689581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.